John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Cato Corp
CATO
$55.7M
| $207K | ﹤0.01% |
62,183
-38,864
| -38% | -$131K |
|
|
VCSA
2777
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $207K | ﹤0.01% |
+38,400
| New | +$198K |
|
2778
Village Farms International
VFF
$331M
| $207K | ﹤0.01% |
341,473
+16,723
| +5% | +$12.2K |
|
2779
Park Hotels & Resorts
PK
$3.19B
| $205K | ﹤0.01% |
19,239
-226,354
| -92% | -$2.87M |
|
2780
Scansource
SCSC
$1.1B
| $205K | ﹤0.01% |
+6,035
| New | +$246K |
|
|
CVAC
2781
DELISTED
CureVac
CVAC
| $204K | ﹤0.01% |
73,770
-40,915
| -36% | -$142K |
|
2782
Broadridge
BR
$21.1B
| $204K | ﹤0.01% |
842
-400
| -32% | -$94.1K |
|
2783
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$44.2M
| $203K | ﹤0.01% |
+5,800
| New | +$212K |
|
2784
iShares US Basic Materials ETF
IYM
$1.04B
| $202K | ﹤0.01% |
+1,500
| New | +$204K |
|
2785
Cass Information Systems
CASS
$735M
| $202K | ﹤0.01% |
4,661
-6,874
| -60% | -$292K |
|
2786
Franklin US Small Cap Multifactor Index ETF
FLQS
$49.9M
| $201K | ﹤0.01% |
+5,100
| New | +$211K |
|
2787
BRC Group Holdings
RILY
$283M
| $200K | ﹤0.01% |
51,570
+2,350
| +5% | +$10.7K |
|
2788
nLIGHT
LASR
$2.54B
| $199K | ﹤0.01% |
25,563
-97,996
| -79% | -$986K |
|
2789
Prothena Corp
PRTA
$482M
| $198K | ﹤0.01% |
16,033
-22,361
| -58% | -$316K |
|
2790
Nuvectis Pharma
NVCT
$778M
| $196K | ﹤0.01% |
20,093
+1,523
| +8% | +$11K |
|
2791
Ultralife
ULBI
$113M
| $195K | ﹤0.01% |
36,336
+11,174
| +44% | +$76K |
|
2792
Evolution Petroleum
EPM
$125M
| $195K | ﹤0.01% |
37,726
+9,515
| +34% | +$49.6K |
|
2793
Mizuho Financial
MFG
$124B
| $195K | ﹤0.01% |
35,369
| – | – |
|
|
HSHP
2794
Himalaya Shipping
HSHP
$780M
| $192K | ﹤0.01% |
35,004
+6,759
| +24% | +$35.4K |
|
2795
UroGen Pharma
URGN
$2.26B
| $191K | ﹤0.01% |
17,288
-39,607
| -70% | -$422K |
|
2796
Fate Therapeutics
FATE
$292M
| $191K | ﹤0.01% |
241,872
-55,234
| -19% | -$67.7K |
|
|
GAU
2797
Galiano Gold
GAU
$633M
| $191K | ﹤0.01% |
154,100
-27,100
| -15% | -$33.3K |
|
2798
NET Power
NPWR
$176M
| $190K | ﹤0.01% |
72,207
+34,119
| +90% | +$241K |
|
2799
LCNB Corp
LCNB
$278M
| $189K | ﹤0.01% |
12,795
-364
| -3% | -$5.47K |
|
|
AEVA
2800
Aeva Technologies
AEVA
$1.15B
| $188K | ﹤0.01% |
26,880
-47,408
| -64% | -$195K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.